Delivery Order SPE2DB24D1201-SPE2DB25FJCEH
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$8.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $13,021.65 and runs through March 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,206.68 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $31,971.06 for the medical product REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The award has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,437.19, is a Firm Fixed Price Delivery Order for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a $28,161.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. There is no set-aside designation noted for this contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,154.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 3, 2024 with a completion date of July 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $64,142.21, is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of June 26, 2024 and is a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $17,530.84, is a firm fixed price delivery order for the pharmaceutical product REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract has a period of performance through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a leading...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty pharmaceutical product, with a ceiling value of $33,014.39 and a period of performance through June 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,054.32 delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a prescription medication. The contract has an ultimate completion date of April 24, 2023 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...